Maze Therapeutics, Inc.
USD29.26
+0.26 (+0.90%)
CEO
Jason Coloma
IPO Date
2025-01-31
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$29.15
Prev. Close
$29.00
Day Low
$28.84
Day High
$29.39
52W Low
$10.98
52W High
$53.65
Market Cap
$1.62B
Volume
0.09M
| 13.4 |
| 31 Dec 2023 | FY | 0.0% | 0.0% | -998.8% | -140.4% | 4.94 | 2.09 | -7.0 |
| 31 Dec 2022 | FY | 0.0% | 0.0% | -113.3% | -76.6% | 0.32 | 5.11 | -6.1 |
| -12.9 |
| 30 Sept 2025 | Q3 | 0.0% | 0.0% | -7.9% | -7.1% | 0.06 | 17.70 | -9.9 |
| 30 Jun 2025 | Q2 | 0.0% | 0.0% | -12.8% | -11.1% | 0.10 | 13.63 | -4.0 |
| 31 Mar 2025 | Q1 | 0.0% | 0.0% | -11.2% | -9.9% | 0.09 | 16.10 | -3.7 |
| 31 Dec 2024 | Q4 | 0.0% | 0.0% | -15.0% | -12.3% | 0.14 | 9.76 | -5.9 |
| 30 Sept 2024 | Q3 | 100.0% | -990.1% | -24.9% | -12.9% | 0.80 | 8.77 | -7.1 |
| 30 Jun 2024 | Q2 | 100.0% | 84.3% | -53.0% | 64.4% | -0.29 | 8.30 | 1.3 |
| 31 Mar 2024 | Q1 | 0.0% | 0.0% | 0.0% | 0.0% | 0.00 | 0.00 | -5.4 |
| 31 Dec 2023 | Q4 | 0.0% | 0.0% | -264.3% | -37.2% | 4.94 | 2.09 | -6.6 |